Patents by Inventor Catherine Vidal

Catherine Vidal has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for characterising a gait
    Patent number: 11229380
    Abstract: A method is provided for characterising a gait comprising steps of: receiving a signal measuring the movement of a target subject measured beforehand; comparing (204) at least one section of the measuring signal with a plurality of reference signals, the plurality of reference signals comprising at least one movement signal measured beforehand on a reference subject different from the target subject, each comparison of the measuring signal with a reference signal producing a similarity coefficient representative of a probability of similarity between the compared signals; and selecting (208) at least one local maximum of interest among the similarity coefficients produced, wherein the plurality of reference signals comprises at least one movement signal measured beforehand on a reference subject afflicted with a gait disorder, and at least one movement signal measured beforehand on a healthy reference object.
    Type: Grant
    Filed: August 5, 2016
    Date of Patent: January 25, 2022
    Inventors: Robert Dadashi, Thomas Moreau, Charles Truong, Catherine Vidal, Alain Yelnik, Rémi Barrois-Muller, Nicolas Vayatis, Laurent Oudre, Pierre Paul Vidal, Damien Ricard
  • Hydroxyphenol derivatives, processes for the preparation thereof, pharmaceutical compositions them, and therapeutic uses thereof
    Patent number: 8653134
    Abstract: Compounds of the formula (I): in which A, R1, R2, X, Y and Z are defined in the description, the processes for the preparation of these compounds, the uses thereof for the treatment of dyslipidaemia, atherosclerosis and diabetes, and the pharmaceutical compositions comprising them.
    Type: Grant
    Filed: December 22, 2005
    Date of Patent: February 18, 2014
    Assignee: Merck Patent GmbH
    Inventors: Catherine Vidal, Nathalie Adje, Stéphane Yvon, Jean Jacques Zeiller
  • Specific caspase-10 inhibitors
    Patent number: 8357721
    Abstract: The invention relates to compounds of the general formula (I) wherein R1, R2, R3, R4, R5, R6, i and j have the meanings given in claim 1, and to the use thereof as caspase-10 inhibitors, especially for the treatment of diabetic retinopathy.
    Type: Grant
    Filed: April 6, 2006
    Date of Patent: January 22, 2013
    Assignee: Merck Patent GmbH
    Inventors: Claude Lardy, Marc Lecomte, Thierry Convard, Catherine Vidal
  • Azaindole inhibitors of MTP and ApoB
    Patent number: 7838533
    Abstract: The present invention relates to 7-azaindole-based compounds, to processes for the preparation thereof, to pharmaceutical compositions comprising them, and to the use thereof in the preparation of medicaments that are useful as inhibitors of MTP and of ApoB secretion.
    Type: Grant
    Filed: June 28, 2005
    Date of Patent: November 23, 2010
    Assignee: Merck Patent GmbH
    Inventors: Alyx Caroline Guevel, Catherine Vidal, Bruno Roux, Olivier Chevreuil
  • Specific caspase-10 inhibitors
    Patent number: 7829721
    Abstract: The invention relates to compounds of the general formula (I), and to their use as caspase-10 inhibitors, especially for the treatment of diabetic retinopathy.
    Type: Grant
    Filed: November 2, 2005
    Date of Patent: November 9, 2010
    Assignee: Merck Patent GmbH
    Inventors: Claude Lardy, Marc Lecomte, Catherine Vidal, Thierry Convard, Stéphane Yvon, Marie Noelle Denuault, Denis Descours
  • Novel Azaindole Inhibitors of Mtp and Apob
    Publication number: 20090036481
    Abstract: The present invention relates to 7-azaindole-based compounds, to processes for the preparation thereof, to pharmaceutical compositions comprising them, and to the use thereof in the preparation of medicaments that are useful as inhibitors of MTP and of ApoB secretion.
    Type: Application
    Filed: June 28, 2005
    Publication date: February 5, 2009
    Inventors: Alyx Caroline Guevel, Catherine Vidal, Bruno Roux, Olivier Chevreuil
  • Novel Specific Caspase-10 Inhibitors
    Publication number: 20080255173
    Abstract: The invention relates to compounds of the general formula (I), and to their use as caspase-10 inhibitors, especially for the treatment of diabetic retinopathy.
    Type: Application
    Filed: November 2, 2005
    Publication date: October 16, 2008
    Inventors: Claude Lardy, Marc Lecomte, Catherine Vidal, Thierry Convard, Stephane Yvon, Marie Noelle Denuault, Denis Descours
  • 6-Phenylhex-5-Enoic Acid Derivatives, Process for the Preparation Thereof, Pharmaceutical Compositions Comprising Them, and Therapeutic Uses Thereof
    Publication number: 20080194608
    Abstract: Compounds of the formula (I): in which R1, R2, R3, R?3 and R4 are as defined in the description, the use thereof for the treatment of dyslipidaemia, atherosclerosis and diabetes, the pharmaceutical compositions comprising them, and the processes for the preparation of these compounds.
    Type: Application
    Filed: December 22, 2005
    Publication date: August 14, 2008
    Inventors: Michel Brunet, Herve Dumas, Catherine Vidal, Nathalie Adje, Benoit Van Hille, Francis Contard
  • Novel Specific Caspase-10 Inhibitors
    Publication number: 20080182906
    Abstract: The invention relates to compounds of the general formula (I) wherein R1, R2, R3, R4, R5, R6, i and j have the meanings given in claim 1, and to the use thereof as caspase-10 inhibitors, especially for the treatment of diabetic retinopathy.
    Type: Application
    Filed: April 6, 2006
    Publication date: July 31, 2008
    Inventors: Claude Lardy, Marc Lecomte, Thierry Convard, Catherine Vidal
  • Hydroxyphenol Derivatives, Processes For The Preparation Thereof, Pharmaceutical Compositions Them, And Therapeutic Uses Thereof
    Publication number: 20080161308
    Abstract: Compounds of the formula (I): in which A, R1, R2, X, Y and Z are defined in the description, the processes for the preparation of these compounds, the uses thereof for the treatment of dyslipidaemia, atherosclerosis and diabetes, and the pharmaceutical compositions comprising them.
    Type: Application
    Filed: December 22, 2005
    Publication date: July 3, 2008
    Inventors: Catherine Vidal, Nathalie Adje, Stephane Yvon, Jean Jacques Zeiller
  • Sulphated polysaccharides, anticoagulant agent and anticomplementary agent obtained from brown algae fucuses and method of obtaining same
    Patent number: 5321133
    Abstract: The invention relates to sulphated polysaccharides obtained from fucuses extracted from pheophyceae. The molecular weight of these polysaccharides is greater than 5 and less than 40 Kda; their sulphur content is greater than that of the original fucus and they contain less than 0.15% of contaminant proteins. Applications as anticoagulant and anticomplementary agents.
    Type: Grant
    Filed: January 16, 1992
    Date of Patent: June 14, 1994
    Assignee: Institut Francais de Recherche pour l'Exploitation de la Mer-IFREMER
    Inventors: Sylvia Colliec, Jacqueline Bretaudiere, Patrick Durand, Anne-Marie Fischer, Jacqueline Jozefonvicz, Bernard Kloareg, Catherine Vidal